{"ticker": {"uuid": "38314e76-e42f-4992-9626-79e4422be64c", "symbol": "VBIO", "name": "Valion Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Valion Bio's Entolimod Accepted for Regulatory Review in Ukraine", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-apos-entolimod-accepted-123302559.html", "source_name": "MT Newswires", "published_at": "2026-07-22T12:33:02+00:00", "published_display": "22 Jul 2026 12:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/world-premier-cancer-center-sheba-170500355.html", "source_name": "PR Newswire", "published_at": "2026-07-20T17:05:00+00:00", "published_display": "20 Jul 2026 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1 Valion Bio Inc For: 17 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNazRtdXFTYlBwT2hFNEU2ZmRkazdaNEpkZm9QVzNCS092NzV6c3A1TVBpUmdKNlJCN3o3eXRQZ1VRSkVVOEZ3OTN2aENYcGZIV0luTEY0ekZjaldwTnVDT1RCOXhsWlVDSFpHNU16ektTdmg3MXRKUlRobno4MlZkc1pRRmJaa1hia2E3UjM4MFpIVEF3U09LZ01GVQ?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-18T08:52:06+00:00", "published_display": "18 Jul 2026 08:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Valion Bio Inc For: 17 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPYmdpS1BGQVNsdlZGZFF5MUpMNFNFdXVtejF6SDVBQ0pUXzhlNUJ6NmRHX2xmdWJjaXdUR1RITTh3OXFHSTNhdGFhaXUyZ3diQkZkRHZmOFBTeThFaWxQZ2lZM28tX3dicTljQkpYSmQyWjVLM2dMQlBVZUF5TUtGVFV3c0wxRVc4UDM0ckE1Skd2VVJQUWdvUWdIM2lHcUdFQmc?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-17T21:08:46+00:00", "published_display": "17 Jul 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (OTC: VBIO) investor group caps ownership at 9.99% with blocker", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNWVVvckVIZVBnQlVXZkJyWEphdjltbUtzMGE1U241WlZMZjd5UUltWU5hcEltSnR4NzNCR2t6Z0ZURWg3elJHSnpTb21CZ2EtZ0JoVzdIVkhXMUVhcmM1Q05POFhGOGdIc2VhZnNNeG9hVEd4V0N5QnFvaVVzM2RzVFUwV3ZzdTVCVGRhckpzQVJfNmtlWjBkZXNCTjIyZXFZSjlVWV9jTGZOOU9EM3BEQ0k5N0M3TDNvSkZrVmV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-17T14:17:26+00:00", "published_display": "17 Jul 2026 14:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio, Inc.: Shareholders Board Members Managers and Company Profile | US8887053085", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQdEg0M3N2SXhzUm9UU084VGk0SHNoR1M1NkJQNFZtdV9PdVpZaUx3anhXTjltV2d3RXVFTmhBLWpoQzNNUzM0emY3Rm1tdWpudHpfYmVNcFo1akJybkhCNVFGMnFoYTVqU0NqaXZOMnEzdHhBMGlEWkR2cGdiQ0dqd3FB?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-17T07:00:00+00:00", "published_display": "17 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Valion Bio advances Entolimod platform and manufacturing scale-up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOV0c5TFFrdU5mQUI5NGRmcHp1dEZxTk51eVp4NDRXZm91Tm9GNjBOZmRIMmtyNW1VQmRkbDlNOTJXZDgtM1NxTkdjMV9jY05uU1FPZzZhZ0h1SkZ5bkJxaEhLY1N6SjlZU2VEbkxLQ0xXempqamJHSUZWMmVBSllObVVSTTlTbXd4RWpPeVFfY3JXS3BhYUhTeDlRYkI2Y1A0VXVPMXBpc2NyNUpMdkJMaTdiX3RXX0c5aThRM05OM3NtUGlFX1N3X25RUWFxOThvVkVJUmVrWVo0b0gzamJCTUpYVEMtbGs?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T08:18:00+00:00", "published_display": "16 Jul 2026 08:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Advances Entolimod Program with Government Engagement, Manufacturing Scale-Up, Oncology Supportive Care Plans", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-advances-entolimod-program-123526939.html", "source_name": "MT Newswires", "published_at": "2026-07-14T12:35:26+00:00", "published_display": "14 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (OTC: VBIO) details biodefense and oncology plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNSW4xU1N3b0NGYnJkQzBuQ3dfSmdUWjUzVGJjc1ZmTmo2UHRWRTJ2S2p3WXlWZUlNNlJBRkhtRzlHYXA5QkhGUTJ4Y1pQV2planFxTVMzT0xCZ3NKWlhjSHVKOUdoanc5bXBWZHFPU1NBQ1h2ZkFhU2NfWmtJN2QyYW00TlV6eHRudm5MSzFjaHIyWDYwX0RQeUZqQTlNZzNwdkpRUFp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:37+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-advances-integrated-biodefense-114500867.html", "source_name": "PR Newswire", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Reports Entolimod Scale-Up Equal to ~1.3M Potential Human Doses", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNby12RV9mWXZZaVRiTEs1Ylk3TEhmYVNtY3AyRTRZTzVCYVNUSUoyMEpRbUNFY3dkN0FSSzUtNUp6X0JhbzJ3QmNTWEFpbGpndG5NQkhnM1dhRmd0YW83YlUtakxMdW9USDk3NlRFamNKOFE3bGptVUQxMkh3S3FhNnFNQWpxZWxESzFwQW5GdWNXUUVFRVoxWHJuc3NEaHJBRUtuaGtkUWpkMHUxUkRvTTFHZk9jZlluNHRKeA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/afrri-niaid-designs-proprietary-pbi-114500135.html", "source_name": "PR Newswire", "published_at": "2026-06-25T11:45:00+00:00", "published_display": "25 Jun 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (NASDAQ: VBIO) adds $250,000 via Series B preferred share and warrant sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTEVnRU1NLUlJRklsSHVoMHRjVjRjV2R5cjZzSDE2X1lOMV9KQTMzaW1zZWxQcFVIeHB4QnpHVUVLX1ZRam5XUXJTQlJhd2lick13TXVsVnpYWkd3UHNBVWhveldiM3E5SHpqS2l6RkwwUENxck10UzJxOFlCdUpnYTFxY1VLTEd6b1c3MGVxemExb3VPZ0FMV1dOUkZTMlF2RWVoaFRR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (VBIO) CFO exercises 92 RSUs, holds 618 common shares after conversion", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQbWo2TnloUG9jQXBWOW90U3NUUFVqSTdLRmhtaVNjXzhFamRPbkp5UkJuU3ZYZVlVZjRhUGlSYmgzS1EtSk1tcE9ZTzhGd2NONXY5emczejJsRXNkZ2pOSUM3Mi1Vel9NRExpSFdjLVNwMFlqc3hPTFBxN1RId2JPNW9yOE5sUzhEOWlvYzJqTXZrSnRic1NQMlF5UTIzblBiME40eFVDcHF2VHo5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOSTllSVI1OThWakpaZER5UUt6dHNEQVVnOGphYXhIN0dtX1d6ZWhMOTNNTFV2cnZtWjFIVjlaeGlud19wU3EwRU5iS1JWazBQUFpsNUJTdk91MzR6YVJ0eEt3dnFyU1hLVHRRbHcwTkxYeXpQMXhDeDdGU2hsWXNTR1FQSXR4RklkT3NWRHh6a2Z6ZWFZc0xKaElYaXpveHk2U1E?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bio-briefs-senior-department-203800725.html", "source_name": "PR Newswire", "published_at": "2026-05-19T20:38:00+00:00", "published_display": "19 May 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "VBIO SEC Filings - Valion Bio Inc 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE41TVJaOGswd2hMcFZRb2UyRmN1OFRTczdIWGMyMkZvLXpJeU42VHlGOWRDZ1NlRTdvbUxvd1RLNG0xMksxZ0RiMFBxblFjV21hcXNnMTNzZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-14T22:16:44+00:00", "published_display": "14 May 2026 22:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR\u2122 Platform", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bios-velocity-bioworks-secures-203000577.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:30:00+00:00", "published_display": "14 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bio-reports-first-quarter-200500712.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:05:00+00:00", "published_display": "14 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Valion Bio (VBIO) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1aLXgtVnNJUFloVUNVWU9RdzFYMHBCY0Jxb1BBZWliNVBBTFhQY2FMenJjRWZrekRPQnhmZ1JLSGtNVVJyR0ZneXBsc3JPQQ?oc=5", "source_name": "Stock Titan", "published_at": "2021-08-11T02:06:19+00:00", "published_display": "11 Aug 2021 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Valion Bio's Entolimod Accepted for Regulatory Review in Ukraine", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-apos-entolimod-accepted-123302559.html", "source_name": "MT Newswires", "published_at": "2026-07-22T12:33:02+00:00", "published_display": "22 Jul 2026 12:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/world-premier-cancer-center-sheba-170500355.html", "source_name": "PR Newswire", "published_at": "2026-07-20T17:05:00+00:00", "published_display": "20 Jul 2026 17:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form S-1 Valion Bio Inc For: 17 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNazRtdXFTYlBwT2hFNEU2ZmRkazdaNEpkZm9QVzNCS092NzV6c3A1TVBpUmdKNlJCN3o3eXRQZ1VRSkVVOEZ3OTN2aENYcGZIV0luTEY0ekZjaldwTnVDT1RCOXhsWlVDSFpHNU16ektTdmg3MXRKUlRobno4MlZkc1pRRmJaa1hia2E3UjM4MFpIVEF3U09LZ01GVQ?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-18T08:52:06+00:00", "published_display": "18 Jul 2026 08:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form DEF 14A Valion Bio Inc For: 17 July By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPYmdpS1BGQVNsdlZGZFF5MUpMNFNFdXVtejF6SDVBQ0pUXzhlNUJ6NmRHX2xmdWJjaXdUR1RITTh3OXFHSTNhdGFhaXUyZ3diQkZkRHZmOFBTeThFaWxQZ2lZM28tX3dicTljQkpYSmQyWjVLM2dMQlBVZUF5TUtGVFV3c0wxRVc4UDM0ckE1Skd2VVJQUWdvUWdIM2lHcUdFQmc?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-07-17T21:08:46+00:00", "published_display": "17 Jul 2026 21:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (OTC: VBIO) investor group caps ownership at 9.99% with blocker", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNWVVvckVIZVBnQlVXZkJyWEphdjltbUtzMGE1U241WlZMZjd5UUltWU5hcEltSnR4NzNCR2t6Z0ZURWg3elJHSnpTb21CZ2EtZ0JoVzdIVkhXMUVhcmM1Q05POFhGOGdIc2VhZnNNeG9hVEd4V0N5QnFvaVVzM2RzVFUwV3ZzdTVCVGRhckpzQVJfNmtlWjBkZXNCTjIyZXFZSjlVWV9jTGZOOU9EM3BEQ0k5N0M3TDNvSkZrVmV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-17T14:17:26+00:00", "published_display": "17 Jul 2026 14:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio, Inc.: Shareholders Board Members Managers and Company Profile | US8887053085", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQdEg0M3N2SXhzUm9UU084VGk0SHNoR1M1NkJQNFZtdV9PdVpZaUx3anhXTjltV2d3RXVFTmhBLWpoQzNNUzM0emY3Rm1tdWpudHpfYmVNcFo1akJybkhCNVFGMnFoYTVqU0NqaXZOMnEzdHhBMGlEWkR2cGdiQ0dqd3FB?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-17T07:00:00+00:00", "published_display": "17 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio advances Entolimod platform and manufacturing scale-up", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOV0c5TFFrdU5mQUI5NGRmcHp1dEZxTk51eVp4NDRXZm91Tm9GNjBOZmRIMmtyNW1VQmRkbDlNOTJXZDgtM1NxTkdjMV9jY05uU1FPZzZhZ0h1SkZ5bkJxaEhLY1N6SjlZU2VEbkxLQ0xXempqamJHSUZWMmVBSllObVVSTTlTbXd4RWpPeVFfY3JXS3BhYUhTeDlRYkI2Y1A0VXVPMXBpc2NyNUpMdkJMaTdiX3RXX0c5aThRM05OM3NtUGlFX1N3X25RUWFxOThvVkVJUmVrWVo0b0gzamJCTUpYVEMtbGs?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-16T08:18:00+00:00", "published_display": "16 Jul 2026 08:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Advances Entolimod Program with Government Engagement, Manufacturing Scale-Up, Oncology Supportive Care Plans", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-advances-entolimod-program-123526939.html", "source_name": "MT Newswires", "published_at": "2026-07-14T12:35:26+00:00", "published_display": "14 Jul 2026 12:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (OTC: VBIO) details biodefense and oncology plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNSW4xU1N3b0NGYnJkQzBuQ3dfSmdUWjUzVGJjc1ZmTmo2UHRWRTJ2S2p3WXlWZUlNNlJBRkhtRzlHYXA5QkhGUTJ4Y1pQV2planFxTVMzT0xCZ3NKWlhjSHVKOUdoanc5bXBWZHFPU1NBQ1h2ZkFhU2NfWmtJN2QyYW00TlV6eHRudm5MSzFjaHIyWDYwX0RQeUZqQTlNZzNwdkpRUFp3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:37+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/valion-bio-advances-integrated-biodefense-114500867.html", "source_name": "PR Newswire", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio Reports Entolimod Scale-Up Equal to ~1.3M Potential Human Doses", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNby12RV9mWXZZaVRiTEs1Ylk3TEhmYVNtY3AyRTRZTzVCYVNUSUoyMEpRbUNFY3dkN0FSSzUtNUp6X0JhbzJ3QmNTWEFpbGpndG5NQkhnM1dhRmd0YW83YlUtakxMdW9USDk3NlRFamNKOFE3bGptVUQxMkh3S3FhNnFNQWpxZWxESzFwQW5GdWNXUUVFRVoxWHJuc3NEaHJBRUtuaGtkUWpkMHUxUkRvTTFHZk9jZlluNHRKeA?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:45:00+00:00", "published_display": "14 Jul 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AFRRI/NIAID Designs Proprietary PBI-BM2.5 Protocol to Evaluate Valion Bio's (NASDAQ: VBIO) Entolimod as the First and Only Treatment for GI-ARS", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/afrri-niaid-designs-proprietary-pbi-114500135.html", "source_name": "PR Newswire", "published_at": "2026-06-25T11:45:00+00:00", "published_display": "25 Jun 2026 11:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (NASDAQ: VBIO) adds $250,000 via Series B preferred share and warrant sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTEVnRU1NLUlJRklsSHVoMHRjVjRjV2R5cjZzSDE2X1lOMV9KQTMzaW1zZWxQcFVIeHB4QnpHVUVLX1ZRam5XUXJTQlJhd2lick13TXVsVnpYWkd3UHNBVWhveldiM3E5SHpqS2l6RkwwUENxck10UzJxOFlCdUpnYTFxY1VLTEd6b1c3MGVxemExb3VPZ0FMV1dOUkZTMlF2RWVoaFRR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (VBIO) CFO exercises 92 RSUs, holds 618 common shares after conversion", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQbWo2TnloUG9jQXBWOW90U3NUUFVqSTdLRmhtaVNjXzhFamRPbkp5UkJuU3ZYZVlVZjRhUGlSYmgzS1EtSk1tcE9ZTzhGd2NONXY5emczejJsRXNkZ2pOSUM3Mi1Vel9NRExpSFdjLVNwMFlqc3hPTFBxN1RId2JPNW9yOE5sUzhEOWlvYzJqTXZrSnRic1NQMlF5UTIzblBiME40eFVDcHF2VHo5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOSTllSVI1OThWakpaZER5UUt6dHNEQVVnOGphYXhIN0dtX1d6ZWhMOTNNTFV2cnZtWjFIVjlaeGlud19wU3EwRU5iS1JWazBQUFpsNUJTdk91MzR6YVJ0eEt3dnFyU1hLVHRRbHcwTkxYeXpQMXhDeDdGU2hsWXNTR1FQSXR4RklkT3NWRHh6a2Z6ZWFZc0xKaElYaXpveHk2U1E?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bio-briefs-senior-department-203800725.html", "source_name": "PR Newswire", "published_at": "2026-05-19T20:38:00+00:00", "published_display": "19 May 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VBIO SEC Filings - Valion Bio Inc 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE41TVJaOGswd2hMcFZRb2UyRmN1OFRTczdIWGMyMkZvLXpJeU42VHlGOWRDZ1NlRTdvbUxvd1RLNG0xMksxZ0RiMFBxblFjV21hcXNnMTNzZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-14T22:16:44+00:00", "published_display": "14 May 2026 22:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR\u2122 Platform", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bios-velocity-bioworks-secures-203000577.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:30:00+00:00", "published_display": "14 May 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/valion-bio-reports-first-quarter-200500712.html", "source_name": "PR Newswire", "published_at": "2026-05-14T20:05:00+00:00", "published_display": "14 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Valion Bio (VBIO) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1aLXgtVnNJUFloVUNVWU9RdzFYMHBCY0Jxb1BBZWliNVBBTFhQY2FMenJjRWZrekRPQnhmZ1JLSGtNVVJyR0ZneXBsc3JPQQ?oc=5", "source_name": "Stock Titan", "published_at": "2021-08-11T02:06:19+00:00", "published_display": "11 Aug 2021 02:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 76, "total_relevant": 29, "sentiment_summary": {"positive": 2, "negative": 1, "neutral": 26, "score": 50, "total": 29, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 4.26, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.51, "latest_week": "2026-07-17", "one_week_move": -0.8, "four_week_move": -2.8, "twelve_week_move": -62.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.30547, "market_dynamics_buy_signal": false, "relative_strength": -74.100968, "fair_value_gap": -95.6, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 35.861, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.8% over one week, -2.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 7}, {"label": "Market source", "count": 7}, {"label": "PR Newswire", "count": 6}, {"label": "MT Newswires", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "Investing.com Canada", "count": 1}, {"label": "marketscreener.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 10}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.8% over one week, -2.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Valion Bio's Entolimod Accepted for Regulatory Review in Ukraine"}], "updated_at": "2026-07-22T13:37:03.915224+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}